Delivery Order SPE2DB24D2011-SPE2DB24FBPAQ

Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $31K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MULTAQ 400 MG TABLET 60S pharmaceuticals. The $17,601.39 contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S pharmaceuticals. The firm fixed price contract has a ceiling value of $5,022.15 and a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, that serves as the primary...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MULTAQ 400 MG Tablet 60s. The $14,014.66 contract has a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,850.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563556699 MULTAQ 400 MG TABLET 60S. The firm fixed price contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,793.26 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of MULTAQ 400 MG TABLET 60S. This contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,558,085,095 MULTAQ 400 MG TABLET 60S. The $111,931.36 contract has an August 15, 2022 completion date and was awarded on August 12, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $19,061.10 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,449,026 units of the pharmaceutical product MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has a ceiling value of $9,785.14 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp, as the prime contractor, has also been awarded an indefinite delivery contract (IDC) by DLA with a potential value of...
The Defense Logistics Agency (DLA) awarded a $1,907.60 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $42,929.06 contract is for the supply of the prescription medication MULTAQ 400 MG TABLET 60S. The delivery order has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation....
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPAQ
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S pharmaceutical products. The $30,585.59 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense (DOD). This delivery order was not set aside for any particular business category.

Generated 6/20/24, 9:34 AM